Chapter 18: Beyond the Control of Individual Genes - Cancer and Cell Cycle Regulation

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/16

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards detailing cancer-critical genes, cell cycle checkpoints, oncogene activation mechanisms, and the multistep model of colorectal cancer development.

17 Terms

1
New cards
<p>Apoptosis</p>

Apoptosis

Programmed cell death or "cell suicide" that is triggered when DNA damage cannot be repaired, characterized morphologically by membrane blebbing.

2
New cards

Proto-oncogenes

Normal genes located on various chromosomes that code for proteins that stimulate normal cell growth and division, acting as a "GO" signal or "accelerator" for the cell cycle.

3
New cards

Oncogenes

Cancer-causing genes that arise from mutated proto-oncogenes, becoming inappropriately active and overstimulating cell division ("mitosis gone crazy").

4
New cards

Tumor-suppressor genes

Genes that code for proteins that act like "brakes" to inhibit cell division by pausing the cell cycle, repairing damaged DNA, or initiating apoptosis.

5
New cards

G1G_1 Checkpoint

A regulatory checkpoint in interphase that assesses whether conditions are acceptable to begin DNA replication.

6
New cards

G2G_2 Checkpoint

A regulatory checkpoint following DNA synthesis that inspects for DNA replication errors and general DNA damage.

7
New cards

MM Checkpoint

A mitotic checkpoint that verifies whether chromosomes are properly aligned and ready to separate.

8
New cards

Gene Amplification

A genetic alteration where multiple copies of a proto-oncogene are produced, resulting in an excess of normal growth-stimulating protein.

9
New cards

Translocation or Transposition

A chromosomal alteration where a proto-oncogene is relocated adjacent to a new, highly active promoter, leading to normal growth-stimulating protein being produced in excess.

10
New cards

Point Mutation (in Proto-oncogenes)

A single-base change either within a control element (leading to excess normal protein) or within the protein-coding sequence itself (yielding a hyperactive or degradation-resistant protein).

<p>A single-base change either within a control element (leading to excess normal protein) or within the protein-coding sequence itself (yielding a hyperactive or degradation-resistant protein).</p>
11
New cards

rasras Gene

A cell cycle regulatory gene that acts as a proto-oncogene; mutations leading to an active oncogene are implicated in approximately 30%30\% of human cancers.

12
New cards

p53p53 Gene

A crucial tumor-suppressor gene coding for a protein that stops division and facilitates apoptosis following DNA damage; mutated or lost in approximately 50%50\% of human cancers.

13
New cards

BRCABRCA Gene

A tumor-suppressor gene whose functional protein repairs damaged DNA; mutations prevent repair and allow damaged cells to divide uncontrollably and accumulate additional mutations.

14
New cards

Polyp

A small benign epithelial growth on the colon wall, commonly initiated by the loss of the tumor-suppressor gene APCAPC.

15
New cards

Adenoma

A larger benign colon growth that forms when cells of a polyp accumulate further genetic changes, such as the activation of the rasras oncogene and the loss of the DCCDCC tumor-suppressor gene.

16
New cards

Carcinoma (Colorectal)

A malignant tumor of the colon that develops after successive mutations, including the loss of the p53p53 tumor-suppressor gene alongside other accumulated genetic changes.

17
New cards

Multistep Model of Cancer Formation

The paradigm describing cancer development as a gradual process typically requiring about 12\frac{1}{2} dozen (66) DNA alterations, including the activation of at least one oncogene and the loss of tumor-suppressor genes.

<p>The paradigm describing cancer development as a gradual process typically requiring about $$\frac{1}{2}$$ dozen ($$6$$) DNA alterations, including the activation of at least one oncogene and the loss of tumor-suppressor genes.</p>